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Abstract: We investigated the involvement of poly­
morphonuclear granulocytes (PMN) and monocytes 
in cartilage degradation in immune complex-mediated 
arthritis (ICA). ICA induced with lysozyme-anti- 
lysozyme in the murine knee joint is characterized 
by a major influx of PMNs followed by monocytes and 
marked cartilage proteoglycan (PG) depletion devel­
ops within 2 days. Around 60% of 35S-prelabeled PG 
is lost at day 2 . Influx of cells was manipulated using 
interleukin-1 (IL-1) receptor antagonist (IL-lra) or anti­
bodies to adhesion molecules. Cellular infiltrate was 
analyzed on hematoxylin-stained joint sections. Early 
systemic treatment with IL-lra highly reduced PMN 
influx, whereas monocyte influx was hardly diminished. 
PG loss was not significantly reduced, declining from  
62% in controls to 47% in IL-lra-treated mice. Total 
blockade of cell influx was found after intravenous treat­
ment with monoclonal antibodies 5C6 (anti-C D llb/
CD18:anti-CR3) or NIMP.R14 (25—3 0  kDa protein
mainly present on PMN) and PG loss was reduced to 
5—10%. A similar reduction was observed after prior 
depletion of circulating PMNs with total body irradi­
ation. Because amounts of IL-1 produced in leuko­
penic and control arthritic joints are comparable, this 
suggests that IL-1 is only marginally involved in PG 
loss in the first phase of ICA. This study indicates that 
monocytes rather than PMN might be involved in PG 
loss in this form of arthritis, either directly or by local 
activation of synovial layer cells of the joint. J. Leu-
koc. BioL 61: 2 6 7 -2 7 8 ;  1997.
Key Words: experimental arthritis *  interleukin-1 • proteoglycan 
depletion
INTRODUCTION
One of the main pathological features of acute human and 
experimental arthritis is cartilage damage [1—3]. Proteogly­
cans (PG), important constituents of the cartilage matrix, 
are degraded and set free in the joint cavity. Besides deg­
radation, the formation of new PGs by the chondrocyte is
strongly inhibited thus preventing recovery of the matrix 
[1]. The exact mechanism(s) involved in PG degradation is 
still unknown but recent studies suggest that PG are de­
graded between the G1-G2 domain by an unknown en­
zyme called aggrecanase [4]. The presence of neutrophils 
and monocytes/macrophages in joint inflammation is well 
documented. Some studies suggested that the neutrophil 
is involved in the initial stages of cartilage degradation 
[5-7], whereas others gave more emphasis to the monocyte/ 
macrophage [8-10]. The capability of these cell types to 
induce cartilage destruction has been extensively studied 
in vitro. The neutrophil releases many substances with the 
potency to degrade PG like serine [11] or métallo protein as es 
[12]. Earlier studies done by us revealed that, under in vitro 
conditions, elastase was the dominant factor involved in PG 
degradation [13]. In addition, the monocyte/macrophage 
also causes release of proteoglycans if co-cultured with a 
cartilage specimen [14, 15]. Metalloproteinases have been 
shown to be important mediators of PG degradation in such 
experiments [15]. However, although a great deal of in 
vitro evidence has been obtained that indicates that neutro­
phils and monocytes/macrophages are involved in cartilage 
destruction, their active role in vivo is still a matter of de­
bate. During the first phase of arthritis induced by immune 
complexes, severe cartilage damage is observed within a 
few days after induction both in mice [16] and rabbits [17]. 
In the period that cartilage degradation develops, neutro­
phils form the major component of the cell infiltrate, where­
as monocyte number is low. Because complete blockade 
of cell influx prevented the larger part of cartilage degra­
dation it seemed likely that the neutrophil is the dominant 
cell involved in cartilage degradation. However, elastase,
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the dominant cartilage-degrading factor under in vitro con­
ditions seemed unimportant in vivo because arthritis in­
duction caused similar cartilage degradation in elastase- 
deficient Beige mice compared with controls [18]. The 
latter observation casts some doubt on the role of the neu­
trophil as the dominant cartilage-degrading cell.
The objective of the present in vivo study was to further 
investigate the relative role of neutrophils and monocytes/ 
macrophages in cartilage degradation in the early phase 
of experimental arthritis. As a model, immune complex- 
induced arthritis (ICA), which is induced with lysozyme- 
antilysozyme in the murine knee joint, was studied. ICA 
is characterized by early IL-1 production, influx of inflam­
matory cells, and severe cartilage degradation of proteogly­
cans from the cartilage matrix [16]. In the first part of the 
study, kinetic studies on histological sections were done to 
correlate influx of neutrophils and monocytes to the onset 
of cartilage degradation. Subsequently the involvement of 
these cell types in cartilage degradation was studied by 
complete or selective blocking of the influx of inflammatory 
cells into the arthritic joint. Complete inhibition of cell 
influx was achieved with anti-adhesion antibodies or total 
body irradation. Selective inhibition of PMN influx was ob­
tained by IL-lra treatment, in line with the recent obser­
vation that IL-lra inhibits chemokine macrophage inhibit­
ing factor (MIP-2), responsible for PMN attraction in the 
kidney [19]. The effect on cartilage degradation was mea­
sured either semi-quantitatively in total knee joint sections 
stained with safranin-o or quantitatively by measuring the 
release of [35S] sulphate-labeled proteoglycans from the 
patellar cartilage matrix. Our study suggests that mono­
cytes rather than PMN are involved in early cartilage dam­
age during acute arthritis.
MATERIALS AND METHODS
Animals
Normal male C57 BL/6 mice were obtained from Jackson. They were 
fed a standard diet and tap water ad libitum. They were used between 
8 and 12 weeks of age.
Chemicals
Poly-L-Iysine (PLL), lysozyme, and l-ethyl-3(3~dimethyl-aminopropyl) 
carbodiimide were obtained from Sigma Chemical Company, St. Louis, 
MO. N,yV-dimethyl-1, 3-propanediamine was obtained from BDH Chem­
icals Ltd., Poole, U.K.
Lysozyme coupling to PLL
Lysozyme was coupled to PLL according to the method of Danon [20] 
using l-ethyl~3-(3-dimethylaminopropyl) carbodiimide as an activator 
and PLL as a nucleophil as described previously [16]. Free carboxyl 
groups of the protein were then coupled to amino groups of PLL. The 
molecular mass was raised, whereas the isoelectric point remained high, 
as was determined in a 5% polyacrylamide slab gel with 0.8% ampho- 
lines {pH gradient from 3.5 to 9.5). After coupling lysozyme to PLL, 
the products were purified by gel chromatography (Sephadex G75). The 
first peak coming from the column was used for eliciting ICA. The molec­
ular mass appeared to be 74 kDa, as determined by sodium dodecyl 
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE).
Induction of ICA
Three micro grams of PLL-coupled lysozyme were injected into the right 
knee joint of mice that were previously (4 h before PLL-lysozyme injec­
tion) given specific antisera (0.2 mL) directed against lysozyme intra­
venously. These antisera were raised in rabbits and the titer for lysozyme 
appeared to be 15 (serum dilution) as measured with an enzyme-linked 
immunosorbent assay [16]. The antiserum was decomplemented by heat­
ing at 56° C for 30 min. The left knee joint was injected with saline and 
served as control. Additional controls were mice that got normal rabbit 
serum instead of specific anti-lysozyme. Intra-articular injection of 3 p,g 
of PLL.lys into the knee joint in the absence of specific anti-lysozyme 
antibodies did not cause inflammation or cartilage damage.
Histology
Total knee joints of mice were isolated 1, 3, 6, 9, 12, 18, 24, or 48 h 
after the induction of arthritis. For standard histology, tissue was fixed 
in 4% formaldehyde in phosphate-buffered saline during 3 days at room 
temperature, decalcified in 5% formic acid in phosphate-buffered saline 
during 7 days, and subsequently dehydrated and embedded in paraffin, 
Paraffin sections were cut at 7 JXm and mounted on gelatin-coated slides. 
Hematoxylin/eosin (H & E) staining was performed to study the inflam­
matory cells and safranin-o staining was performed for studying proteo­
glycan depletion of the cartilage matrix [21].
Measurement of inflammation and cell influx
H & E-stained sections were used to measure the severity of the inflam­
mation. Infiltrate and exudate were scored separately. Infiltrate is de­
fined as influx of leukocytes in the synovial layer, whereas exudate rep­
resents the influx of leukocytes in the joint cavity. The severity was 
determined using an arbitrary score (0-3), performed blindly by two 
observers. Mild cellularity throughout the joint was scored 1, higher 
cellularity 2, and very high cellularity was scored 3.
Furthermore, H & E-stained sections were also used to make a dis­
tinction between infiltrating PMN and mononuclear cells. This distinc­
tion could be made on the basis of cellular morphology using a mag­
nification of 400 X . The amount and type of cell were determined in 
a well-defined area in synovium and synovial cavity by use of an ocular 
graticule. The infiltrated cells were determined in the synovial layer ven- 
trally at the lateral and medial side of the patella. The exudate cells were 
determined in the joint cavity adjacent to areas in which infiltrate was 
measured. Five serial sections spacing 140 fXm of each animal were 
counted.
In vivo manipulation of cell influx
Manipulation of cell influx was accomplished by various approaches. In 
the first approach, mice were depleted of neutrophils by total body ir­
radiation. A single dose of 7.5 Gy was applied at a dose rate of 2 Gy/min, 
with a 13-MeV electron beam from a linear accellerator (CGR Saturne, 
Buc, France). Treatment was started 4 days before induction of arthritis.
In the second approach, monoclonal antibodies directed against 
CR3 (5C6: rat anti mouse:IgG2b, kindly provided by S. Gordon, Uni­
versity of Oxford) or a 25- to 30-kDa epitope mainly present on neutro­
phils (NIMP.R14: rat anti-mouse: IgG2b, kindly provided by M. Strath, 
National Institute for Medical Research, London) were used. The IgG 
fraction present in the ascitis fluid was affinity purified by protein G. 
Both antibodies have been shown to inhibit migration of cells into inflam­
matory fields [22, 23]. Binding of these monoclonal antibodies to acti­
vated PMNs and peritoneal monocytes/macrophages was tested by FACS 
analysis.
Monoclonal antibodies (either 5C6 or NIMPR14, 0.5 mg) were given 
18 h before arthritis induction. In control groups, irrelevant IgG2b mono­
clonal antibodies were given.
In the third approach, selective blockade of neutrophil influx was ac­
complished with the use of human IL-lra (kindly provided by Synergen,
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Fig. 1. Total knee joint sections of mice were screened for infiltrate and exudate cells 1, 3, 6^  9, 12* 18, 24, and 48 h after induction of ICA. 
Synovial infiltration and exudate cells were scored on five semi-serial sections of each specimen, spaced 140 [¿m apart (A). In each section, infiltrate 
and exudate was graded in medial and lateral areas extending from the paLella to the tibia. Scoring was done in a blinded fashion by two observers. 
Synovial infiltrate and joint cavity exudate were graded on a scale from 0 to 3, according to the amount of inflammatory cells in synovium and cavity, 
respectively. Maximal cellular influx is defined as the most that was observed in a given set of experiments. 0, no influx; 1, minimal influx; 2, marked 
influx; 3, maximal influx. Seven mice were measured at each time point. Mean values ± sd  were determined. Note that inflammatory cells infiltrate 
the joint cavity at the synovial/cartilage junction at 3 (B) and 6 h (C). More cells scattered throughout the synovial layer were found at 24 h (D). 
In control knee joints in which phosphate-buffered saline was injected no cell influx was observed (data not shown; H & E; original magnification 
X 100). F, femur; P, patella; JS, joint space; S, synovial layer.
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F ig . 2 . The ratio of PMN and monocytes/macrophages was deter­
mined in synovial layer 1, 3, 6, 12, 18, 24, and 48 h after ICÀ induc­
tion. Seven mice were measured at each time point. Total cell number 
and type of inflammatory cells were determined using an ocular grati­
cule in a well-defined synovial area taken ventraUy at the lateral and me­
dial side of the patella. Absolute cell numbers (mean ± s d ) at several 
time-points were, respectively for PMNs: 5 ± 2, 35 ± 9, 54 ± 5, 62 
± 9, 61 ± 8, 49 ± 7, 46 ± 9 and for monocytes 0, 0, 4 ± 3, 14 
± 3, 18 ± 5, 29 ± 5, 47 ± 8 .  The amount of infiltrated cells present 
at 48 h after arthritis induction was taken as reference value 100. The 
line expresses kinetics of cell influx. At every time point the percentage 
of PMN and monocytes/macrophages of total infiltrated cells present at 
that time point was determined.
Boulder, CO). Mini-osmotic pumps (Alzet 1007D; Aka, Palo Alto, CA) 
were implanted into the peritoneal cavity 2 days before arthritis induc­
tion and set to release 50 |j,g of IL-lra/h for the next 7 days. The steady- 
state level of IL-lra in the blood was 4.7 pig/mL from the first day after 
implantation as measured by inhibition of IL-1 effects in an IL-1- 
sensitive bioassay [24].
The effect of the above treatments on numbers of neutrophils and 
monocytes in the peripheral blood was measured using a Hemalog (Tech- 
nicon H-2, Bayer). Four days after total body irradiation, more than 
98% depletion of peripheral neutrophils was found, which persisted for
3 days. One day after NIMP.R14 treatment, 60-70%  depletion of neutro­
phils was found and persisted for 3 days. Treatment with 5C6 or IL-lra 
had no effect on the numbers of monocytes in the peripheral blood.
FACS analysis
Murine neutrophils were isolated using the method of Middleton [25]. 
Normal monocytes/macrophages were isolated from the peritoneal cav­
ity, whereas activated cells were isolated from the peritoneal cavity 2 
days after intrap eri to ne al injection of 40 of lipopolysacch aride. The 
monocyte/macrophage population was enriched by adherence to plastic 
for 1 h at 37 °C. The significance for using LPS-stimulated cells was that 
these cells resemble monocytes infiltrating the arthritic joint, which are 
also activated. Cells (5 X 10s) were incubated with various concentra­
tions (20 ,000-0 ,05  ng/mL) of monoclonal antibody (NIMPR14; 5C6), 
or no monoclonal antibody (irrelevant IgG2b) for Control, at 4°C for 30 
min. After removing unbound antibody by washing two times with 1% 
phosphate-buffered saline, 0.1% bovine serum albumin (BSA), and 
NaN3, pH 7.4, cells were stained with fluorescein isothiocyanate (FITC) 
-conjugated goat anti-rat (Cappel), dilution 1:250 in phosphate-buffered 
saline, 1% BSA, 0,1 Az, and 4% normal mouse serum for 30 min at 
4°C in the dark. The cells were washed two times and analyzed using 
a Coulter Epics XL flow cytometer (Coulter, Hialeah, FL).
Measurement of PG degradation
Semi-quantitative
Total knee joint sections were stained with safranin-o (0.1% safranin-o 
in aqua dest during 10 min at room temperature). The intensity of red 
staining of the cartilage matrix is a measure for PG content in the car­
tilage layer. PG loss was expressed as the percentage of total red staining 
of control noninflamed intact patellar or femoral layers. An arbitrary 
scale of 0 -3  was used with the following range: 0, zero; 1, low; 2, me­
dium; 3, high PG loss.
Quantitative
To study the effect of ICA on in vivo degradation of GAGs, patellas were 
prelabeled by intraperitoneal injection of carrier-free sodium sulfate in
RPMI (35S04, Du Pont, Boston, MA; 50 jiCi/mouse), 4 h before ICA
induction. 5^S was incorporated in newly formed GAGs. More than 
90% of the incorporated radioactivity was confined to the patellar car­
tilage layer compared with the whole patella [26]. After 35S incorpora­
tion, patellas were isolated and patellar content was determined accord­
ing to the method of Van den Berg et al. [27], In brief, patellas were 
fixed in 2% formaldehyde and decalcified in 4% formic acid. After this 
treatment the patella can easily be separated from the surrounding tis­
sue and the labeled PG content can be determined. Cartilage degrada­
tion is defined as loss of 35S from the inflamed patella. The loss of 35S 
is measured by comparison of 35S content of the arthritic patella and 
the contralateral non-arthritic patella,
RESULTS
Kinetics and topography of cell influx and 
cartilage degradation in early ICA
To relate kinetics and location of cartilage degradation to 
influx of PMNs and monocytes at defined sites of the joint, 
total knee joints were dissected at various time points (1,
3, 6, 9, 12, 18, 24, and 48 h) after arthritis induction. 
Sections were stained with H & E. Figure 1A shows that 
cell influx started at 3 h. Infiltrate shows a continuing in­
crease, which reached its maximum at 24 h, whereas ex­
udate reached maximal values at 18 h. Cells mainly entered
9
through blood vessels lying in the synovial layer adjacent 
to the cartilage layers between 3 (Fig. IB) and 6 h (Fig. 1C) 
and were found throughout the synovium at 24 h (Fig. ID).
Characterizing the inflammatory cells by light microscopic 
examination at high magnification it was found that PMNs 
first entered the synovial layer at 3 h followed by mono­
nuclear cells at 6 h after ICA onset (Fig. 2). At 6 h, the
contribution of monocytes to the total amount of inflamma­
tory cells was only 10%, but increased thereafter to 30 and 
50% at 24 and 48 h, respectively (Fig. 2).
In addition, cartilage degradation was measured in 
safranin-o-stained sections of the same joints. PG degrada­
tion was scored in an arbitrary way by determining loss of 
red staining from the cartilage matrix. Figure 3 A shows 
that PG degradation started between 12 and 18 h after ar­
thritis induction, thus at a time-point that both PMN and 
mononuclear cells were present in the joint. PG loss started 
at the edge of the cartilage layers of patella and femur just 
adjacent to the blood vessels through which the inflamma­
tory cells entered the joint (Fig. 3, B and C). PG loss was
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Fig. 3 . Loss of proteoglycans from the cartilage was determined 1, 3, 6, 9 ,1 2 , 18, 24, and 48 h after ICA induction. 
Proteoglycan degradation was measured by loss of red staining in total knee joint sections stained by safranin-o. Red 
staining was measured using an arbritrary scale from 0 to 3 (A), according to the amount of PG loss in patella and 
femur, respectively. Maximal PG loss is defined as the most that was observed in a given set of experiments, PG loss: 
0, zero; 1, low; 2, medium; 3, high. Values represent the mean ± s d  of seven mice per time point. No PG loss was 
seen 1 h after ICA induction (B), PG loss started at the synovial/cartilage junction between 12 and 18 h (C). Maximal 
PG loss was observed at 48 h after ICA induction (D). Injection of phosphate-buffered saline alone has no effect on 
PG loss (data not shown; safranin-o, original magnification X  100). P, patella; S, synovium; F, femur; JS, joint space; 
C, cartilage.
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F ig . 4 . The amount of infiltrate and exudate cells was determined in 
total knee joint sections of mice 24 and 48 h after ICA induction in con­
trol and IL-lra-treated mice. Control mice had empty osmotic pumps 
implanted in the peritoneal cavity. Seven mice were measured at each 
time point. Synovial infiltrate and joint cavity exudate were graded on 
a scale from 0 to 3 according to the amount of inflammatory cells pres­
ent in synovium and joint cavity, respectively. 0» no influx; 1, minimal 
influx; 2, marked influx; 3, maximal influx. Values were statistically eval­
uated using the Mann-Whitney U test (*P  <  0.05). Note the significant 
lower amounts of inflammatory cells in infiltrate at day 1 and both ex­
udate and infiltrate at day 2 after IL-lra treatment.
maximal at 48 h after arthritis induction (Fig. 3D) and re­
covered thereafter. Full replenishment of PG in the cartilage 
matrix was found at day 7 after induction (data not shown).
Selective blockade of neutrophil but not 
monocyte influx by IL-1ra treatment
Because both PMN and mononuclear cells are present dur­
ing the onset of early cartilage degradation, blockade of 
one of the cell types can give information about the contri­
bution of the other cell type in cartilage degradation. The 
approach we chose was blocking IL-1 effects by IL-lra, 
which recendy has been shown to selectively block PMN 
influx in inflamed areas of the kidney [19]. IL-lra was 
given systemically, using mini-osmotic pumps that contin­
uously release 1.2 mg IL-lra per day. Implantation of mini- 
osmotic pumps was done 2 days before arthritis induction 
to reduce stress. To check the efficacy of IL-lra treatment, 
washouts of synovial specimen, taken 6 h after the onset 
of arthritis, were tested for IL-1, using a sensitive IL-1 bio- 
assay. In contrast to IL-1 levels in arthritic controls (20-40  
pg/mL), IL-1 could not be detected in the IL-lra group (be­
low 1 pg/mL). Studying hematoxylin-stained knee joint sec­
tions we found in the IL-lra-treated group a significant de­
crease in influx of inflammatory cells both at day 1 and day 
2 after arthritis induction: synovial infiltrate and exudate 
was significantly inhibited at day 1 and 2, respectively 
(Fig? 4). In IL-lra-treated animals, inflammatory cells 
were mainly detected within the synovial layer and only a 
few cells resided within the joint space, in contrast to con­
trol arthritic joints in which numerous inflammatory cells 
were detected both in synovium and joint space.
Selective effects on influx of particular cell types was 
further analyzed by H & E staining. In the IL-lra-treated 
group, neutrophils were significantly decreased at days 1 
and 2 after arthritis onset (Table 1 and Fig. 5, A and 
B). It was of interest that the absolute number of mononu­
clear cells was not changed by the IL-lra treatment (Table 
1). This was found both in infiltrate and exudate. High- 
power micrographs show abundant PMN and monocytes/ 
macrophages in day 2 arthritic joints (Fig. 5C), whereas 
in IL-lra-treated arthritic joints predominantly monocytes/ 
macrophages were found (Fig. 5D).
Monocyte influx during ICA is sufficient for 
the larger part of cartilage degradation
PG loss of patellar and femural surfaces was scored semi- 
quantitatively in safranin-o stained sections. Surprisingly, 
although IL-ra treatment almost completely inhibited influx 
of neutrophils, PG loss (Fig. 6) was still high. In the IL- 
lra-treated mice, PG loss as detected by loss of red staining 
was similar at the lateral but less at the medial site of the 
cartilage layer if compared with control arthritis. IL-lra 
treatment inhibited PG loss from patella and femur not sig­
nificantly at day 1 and day 2 compared with arthritic con­
trols. Furthermore, we determined PG loss quantitatively 
by measuring loss of prelabeled 35S proteoglycans from
patellas. At day 2 after ICA induction 62% degradation of 
proteoglycans was found. In the IL-lra-treated group, there 
was still 47% PG release from the cartilage layer, which 
was not significandy different from control arthritic joints.
Complete blockade of PMN and mononuclear 
cell influx by total body irradiation or 
anti-adhesion antibodies
Whether inflammatory cells are necessary for cartilage deg­
radation seen within this model was further studied by total 
blockade of cell influx at the onset of arthritis using either 
total body irradation or antibodies directed against mem­
brane epitopes (5C6;NIMPR14). The latter antibodies
TABLE 1. Effect of IL-lra Treatment on Absolute Numbers 
of Neutrophils and Monocytes in Infiltrate and Exudate
at Day 1 and 2 After ICA
Neutrophils Monocytes
Treatment Infiltrate Exudate Infiltrate Exudate
ICA day 1 1 1 9  ± 36 84  ± 12 105 ±  18 47 ±  17
ICA day 1
IL - lra 18  ± 3a 31 ±  12“ 102 ±  11 73 ± 18
ICA day 2 145  ± 14 87 ± 20 144  ±  35 37 ± 4
ICA day 2
IL - lra 25  ± 6a 30 ± 19a 124  db 12 53 ± 11
Absolute numbers of PMN and monocytes/macrophages were determined in 
infiltrate and exudate cells 1 and 2 days after ICA induction in control and IL- 
lra-treated mice. Cell numbers were counted at a well-defined area in synovium 
and joint cavity between patella and femur using an ocular graticule (magni­
fication x  400). Note that IL-lra treatment significantly diminished PMN num­
bers but not monocyte numbers. Five serial sections per animal were studied. 
Values represent the mean ± s d  of six animals. 
aP <  0.05 by the Mann-Whitney U test.
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Fig. 5 . The ratio of PMN and monocytes/macrophages was determined in infiltrate and exudate cells, 1 and 2 days after ICA induction in control 
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were detected (D) original magnification X 400. S, synovium; JS, joint space.
were tested by FACS analysis using activated murine PMNs trast NIMPR14 predominantly binds to PMNs and only 
or mononuclear cells. 5C6 (anti-CDllb CD18) preferen- weakly to mononuclear cells (Fig. 7). 5C6 treatment had 
tially binds to mononuclear cells and less to PMNs, In con- no effect on numbers of peripheral PMNs or mononuclear
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Fig. 6 . The effect of IL-lra treatment on cartilage degradation was determined 24 and 48 h after ICA induction either 
semi-quantitatively by loss of red staining in patella and femur in total knee joint sections stained by safranin-o or quan­
titatively by release of 35S-labeled proteoglycans from patellar cartilage. Red staining was measured using an arbritrary 
scale from 0 to 3. PG loss: 0, zero; 1, low; 2, medium; 3, high. In IL-lra-treated animals, cartilage degradation was 
still high (not significant from controls) both 24 (A, D) and 48 h (B, E) after ICA induction. Loss of 35S prelabeled 
PG was measured at 48 h after ICA induction. PG content in the patella derived from the arthritic joint (arthritic) is 
compared with PG content in the patella from the noninflamed contralateral knee joint. Again high PG loss was observed 
in the IL-lra-treated group (47%) not significantly different from that observed in control arthritis (62%; C). Values 
represent the mean ± s d  of two experiments. In each experiment at least six mice per time point were tested. Values were 
statistically evaluated using the Mann-Whitney U test (* P  <  0.05).
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Fig. 7. Binding of monoclonal antibodies to activated PMNs and mono­
cytes/macrophages were tested by FACS analysis. PMNs or monocyte/ 
macrophages were incubated with monoclonal antibody (NIMPR14;5C6) 
or no monoclonal antibody (irrelevant IgG2b) for control, additionally 
stained with FITC-conjugated goat anti-rat and analyzed by FACS. 
NIMP.R14 preferentially bound activated PMN (A), whereas 5C6 pref­
erentially bound normal or activated monocytes/macrophages (B). No 
significant binding of control monoclonal antibody was found (data not 
shown). Peritoneal exudate cells were isolated from normal mice or from 
mice 2 days after intraperitoneal injection of 40 pg of LPS. The plastic 
adherent cells appeared to be monocytes/macrophages* PEC, peritoneal 
exudate cells; LPS PEC, lipopolysaccharide-stimulated peritoneal ex­
udate cells; PMN, polymorphonuclear cells; GFL, mean green fluores­
cence per cell.
cells as detected by hemalog. NIMPR14 treatment, how­
ever, showed 30-40%  reduction of peripheral PMNs. Both 
irradiation or pretreatment of mice with 0.5 mg of either 
intravenous NIMPR14 or 5C6 completely prevented cell 
influx as seen 48 h after arthritis induction (Fig. 8A).
Cell influx is necessary for cartilage degradation
PG loss as measured in safranin-o-stained sections was al­
most absent in irradiated or antibody-treated arthritic joints 
(Fig. 8B). If cartilage degradation was measured by loss 
of 35S-prelabeled proteoglycans we found between 50 and 
60% degradation in control arthritic joints. Prevention of 
cell influx almost completely protected cartilage destruc­
tion and proteoglycan loss was only between 5 and 10%
(Fig. 8C). Nevertheless there was still production of inflam­
matory mediators in such joints. IL-1 production was sim­
ilar or even elevated in arthritic joints devoid of leukocytes 
(data not shown).
DISCUSSION
In this study we obtained evidence that in an arthritic knee 
joint in the absence of infiltrating inflammatory cells PG 
loss was almost completely blocked. Moreover, in the pres­
ence of merely monocytes/macrophages, severe PG loss is 
found not significantly different from PG loss found in con­
trol arthritic joints in the presence of both neutrophils and 
monocytes/macrophages.
Migration of both neutrophils and monocytes to the in­
flamed knee joint in our non-T cell-mediated ICA model 
was fully blocked by the monoclonal antibody 5C6 (anti- 
CDllb) or NIMPR14. Although 5C6 binds preferentially 
to monocytes/macrophages, whereas NIMPR14 binds pref­
erentially to PMN, some binding was found to the other 
cell type. Blockade of 5C6 or NIMPR14 epitopes on both 
cell types might explain the full blockade of cell influx after 
ICA induction. Moreover these antibodies may have their 
effect after binding of inflammatory cells to endothelial 
cells, which may result in reduction of adhesion molecules 
necessary for penetration.
CDllb seems to be a crucial adhesion molecule in­
volved in cell migration to non-T cell-mediated inflamma­
tory areas because full blockade was also found in the pul­
monary response to aerosolyzed lipopolysaccharide [28] 
or the cutaneous response to tumor necrosis factor 
(Shwartzmann reaction) [28]. In T cell-mediated inflamma­
tory processes, however, such as adjuvant arthritis, CD 11a 
and CDllc appeared to be more important [29], NIMPR14,
which is directed against an unknown 20- to 25-kDa sur­
face protein and preferentially binds to neutrophils also 
completely prevented influx of both cell types. Similar re­
sults were again found in the Shwartzmann reaction [23].
It was of interest that neither NIMPR14 nor 5C6 treat­
ment was able to inhibit cell influx completely in the T 
cell-mediated antigen-induced arthritis [unpublished re­
sults], suggesting that, in this model, different adhesion 
molecules are important for cell influx in the joint.
Full blockade of inflammatory cells to the arthritic joint 
prevented cartilage degradation from 60% in controls to 
5—10% in leukopenic joints. Similar results were found in 
knee joints of neutropenic rabbits in which arthritis was in­
duced by either immune complexes [17] or LPS [30], Our 
findings indicate that sole activation of resident cells of the 
synovial tissue by immune complexes, in the absence of 
cell influx, is not causing major cartilage degradation. How­
ever, we did find marked production of inflammatory me­
diators like IL-1 in murine leukopenic arthritic joints, 
which appeared to be even higher than in control arthritic 
joints [18]. Local production of IL-1 by resident cells may 
well be responsible for the 5-10%  PG loss, as measured 
in neutropenic arthritic joints, by activating chondrocytes
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Fig. 8 . Effect of total blockade of cell influx on cartilage degradation. Cell influx was blocked with either total body irradiation or 0.5 mg of either 
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or synovial cells to release PG-degrading enzymes. Al­
though the amount of IL-1 formed in the leucopenic ar­
thritic joint still causes high inhibition of PG synthesis [18], 
it may be too low to cause severe PG loss. Higher concen­
trations of IL-1 are needed to cause PG degradation com­
pared with PG synthesis. Moreover, direct effects of IL-1
on PG loss are only marginal in mouse cartilage if com­
pared with, e.g.5 bovine cartilage [31, 32].
In addition, we selectively blocked the neutrophil from 
entering the arthritic joint. Recent studies done by Tam 
et al. have shown that IL-lra treatment during acute glo­
merulonephritis preferentially inhibited neutrophil influx,
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whereas monocyte influx was hardly affected [19]. IL-lra 
treatment inhibited mRNA levels of the neutrophil chemo- 
attractant factor MIP-2 by 72%, whereas the monocyte 
chemoattractant factor (MCP-1) was only inhibited by 27%. 
In our study the number of monocytes was not altered sig­
nificantly by the IL-lra treatment, whereas PMN influx de­
creased considerably. These results suggest that IL-1 is not 
responsible for monocyte influx during ICA. Other cy­
tokines like interferon-y [33] or transforming growth factor- 
P [34] or direct activation of resident cells by cationic IC 
may be responsible for production of chemotactic factors 
directing monocyte influx, like MCP-1.
We further studied cartilage degradation quantitatively 
by 35S-PG release and found that PG degradation con­
tinued for the larger part in the IL-lra treated group (from 
62% in controls to 47% in IL-lra-treated animals). In com­
bination with the finding that the minor loss of PG (5~ 
10%) in neutropenic arthritic joints is probably mediated 
by IL-1, this strongly suggests that cartilage destruction in 
this IC model is caused by an IL-l-independent monocyte/ 
macrophage activation. In other models like antigen-induced 
arthritis, we also found that, using IL-lra treatment, IL-1 
is not a key mediator directly involved in the PG degrada­
tion observed in the acute phase of this arthritis [24], but 
has a role in synovial cell activation and propagation of late 
PG degradation. Moreover, IL-1 has been shown to be the 
crucial cytokine involved in inhibition of PG synthesis [35]. 
So in the recovery phase starting shortly after the initial PG 
degradation, the absence of IL-1 allows for restoration of 
the PG content in the cartilage [24]. Also in ICA, a more 
rapid recovery of PG content was observed in IL-lra- 
treated animals at day 7 (data not shown) but such an effect 
was not seen as early as day 2 after ICA.
In control ICA, cartilage degradation started between 
12 and 18 h, a time-point at which monocytes comprise 
only 10-30% of the total inflammatory cell population. In 
control arthritic joints, PG loss started at the synovial car­
tilage junction. A similar pattern of cartilage degradation 
was found in IL-lra-treated animals. At these sites, the ma­
jority of monocytes/macrophages but also expression of pro- 
inflammatory cytokines are detected [36]. This might sug­
gest that monocytes residing in the synovial layer near the 
cartilage might be more important in cartilage degradation 
than exudate cells entering the joint space. If substances 
released by free-floating cells like enzymes or oxygen rad­
icals were important for cartilage degradation, one would 
expect a more homogenous release of PG from patellar, 
tibial, and femural surfaces because joint movement will 
equally disperse enzymes in the joint space. The released 
substances are probably neutralized in the synovial fluid, 
which has been shown to contain a wide array of inhibitors
[37].
The monocyte/macrophage produces more than one 
hundred substances ranging from 30 (nitric oxide) to 
440,000 daltons (fibronectin) [38]. Proteinases like metal-
loproteinases are synthesized after stimulation and produc­
tion takes some time. PMN release their contents direcdy 
after stimulation. The time gap of 9 h between the first ap­
pearance of neutrophils and cartilage degradation does not 
favor this cell type as important for degradation, although 
it could be a cumulative effect. Furthermore, the start of 
cartilage degradation at the synovial/cartilage junction at 
the moment that monocytes are present might suggest that 
released proteinases might escape from enzyme inhibitors 
present in the synovial fluid by the close contact.
In addition, monocytes/macrophages may act indirectly 
by activating fibroblasts. Studies done by Janusz and Hare 
showed that the interaction between these two cell types el­
evated cartilage degradation [15]. During activation of syno­
vial cells many enzymes are released, most of them in their 
inactive proform. Monocytes have been shown to produce 
urokinase-type plasminogen activator (u-PA) and tissue - 
type plasminogen activator (t-PA) [39]; These substances 
might increase proteolytic activity by transforming the en­
zyme proform into its active counterparts. Furthermore 
monocytes/macrophages are important producers of cyto­
kines like IL-1 or tumor necrosis factor, which have been 
shown to activate fibroblasts or resident lining macrophages 
that have been shown to direct the larger part of the inflam­
matory response [40, 41]. Under chronic inflammatory 
conditions the contribution of infiltrating inflammatory cells 
might be less important [42]. Under such circumstances, 
resident fibroblasts and macrophages might become more 
sensitive and develop higher potency to degrade cartilage 
components after contact with cell-activating triggers.
This study indicates that in vivo the monocyte rather 
than the neutrophil seems to be involved in cartilage deg­
radation during arthritis induced by immune complexes. 
Recent clinical studies have claimed that, during rheuma­
toid arthritis, macrophages rather than other cell types like 
T or B cells show strong correlations to cartilage degrada­
tion [8, 43], As immune complexes are generally found in 
the synovial and cartilagenous layers of rheumatoid arthritis 
patients [44], this mechanism may well play a role in car­
tilage damage that develops during early rheumatoid arthri­
tis. Because activated monocytes/macrophages do release 
a spectrum of substances that may damage cartilage either 
direcdy or indirectly, a therapy that leads to suppression 
of the activated monocyte/macrophage might be promising.
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